Beijing-based Novogene Technology Co., Ltd., a commercial provider of genomic services and solutions with next-generation sequencing (NGS) and bioinformatics expertise, has completed a $75 Million (RMB515 Million) Series B round financing led by China Merchants Bank Co., Ltd.’s CMB International Capital Management (Shenzhen) Co., Ltd. (CMB International).
Other investors participating in the round are SDIC Innovation Investment Management Co., Ltd. (SDIC Innovation) and Shanghai Sigma Square Investment Center LP (Sigma Square Capital).
